Akrit Sodhi is an Ophthalmology physician affiliated with Johns Hopkins University. OpenAlex indexes 110 publications with 6,172 citations (h-index 42). By OpenAlex citation count, this profile ranks in the top 10% of Ophthalmology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St
Maumenee 2nd Floor
Baltimore, MD 212870005
Telephone
410-955-3518Registry record last updated 19 Feb 2013.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Dompe US, Inc.Program year20251 payment
- Alcon Vision LLCProgram year20241 payment
- ABBVIE INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
73%Antineovascularisation agents71.9%Faricimab-svoa100%Part B, office-administered≥15 patientsCorticosteroid0.9%Prednisolone Acetate100%Part D≥26 patients+ 1 more class in this area
Cancer & immunology
26.3%Vascular Endothelial Growth Factor Inhibitor26.3%Aflibercept100%Part B, office-administered≥164 patientsMusculoskeletal
0.7%Cyclooxygenase Inhibitor0.7%Ketorolac Tromethamine100%Part D≥18 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- Hypoxia Inducible Factors and Hypoglycemia in Early Diabetic Eye Disease
Johns Hopkins University
FY2026$519,721R01EY035889 - Hypoxia Inducible Factors and Hypoglycemia in Early Diabetic Eye Disease
Johns Hopkins University
FY2025$472,725R01EY035889 - Elucidation of novel anti-angiogenic therapies for the prevention and treatment of neovascular glaucoma
University of Maryland Baltimore
FY2024$584,568R01EY032104
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Roger Blumenthal, MD
Johns Hopkins University
Erin Michos, MD
Johns Hopkins University
Morgan Grams, MD
Johns Hopkins University
Mario Eisenberger, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”